Response to: Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period. Nightingale S, Dreyer AJ, Gisslen M, Winston A, et al. AIDS 2021;35:1152-1153.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nightingale S, Dreyer AJ, Gisslen M, Winston A, et al. Response to: Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period. AIDS 2021;35:1152-1153.
PMID: 33946092